Delivery Order SPE2DB22D3016-SPE2DB24FAXF1
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS medical supplies. The $13,965.55 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 7, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,038.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566449785 CEFEPIME-DEXTROSE 2 GM/50 MLS, a medical product, with a completion date of November 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with a Set-Aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,717.32, is for the delivery of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product, with a performance period ending on January 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,107,064 units of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. This $23,944.67 award has an ultimate completion date of March 29, 2024 and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp by DLA. The IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,054.30 Firm Fixed Price Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.93 firm fixed-price delivery order, which has an ultimate completion date of October 17, 2024, is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,497.09 firm-fixed price delivery order contract has a ceiling value of $1,497.09 and an ultimate completion date of February 5, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,771.72 firm fixed-price delivery order contract has a completion date of June 3, 2024 and is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,959.26 Firm Fixed Price delivery order contract has an ultimate completion date of December 24, 2024 and is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,876.14 firm fixed-price delivery order contract has a completion date of July 10, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAXF1Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product. The $2,808.83 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 3, 2024 with a completion date of June 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also has a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs. This contract award was not designated with a set-aside requirement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 6/3/24 |